Bristol-Myers Squibb and 3 Top Pharma Stocks with Earnings Investors Must See

Amgen Inc. (NASDAQ:AMGN) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Net income decreased -15.63% to $788 million ($1.4 per diluted share) in the quarter versus a net gain of $934 million in the year-earlier quarter. Revenue rose 11.25% to $4.42 billion from the year-earlier quarter.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Amgen Inc. reported adjusted net income of $1.4 per share. By that measure, the company beat the mean analyst estimate of $1.39. It beat the average revenue estimate of $4.37 billion.

AMGN

Celgene Corporation (NASDAQ:CELG) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Net income increased 39.45% to $572 million ($1.32 per diluted share) in the quarter versus a net gain of $410.18 million in the year-earlier quarter. Revenue rose 10.29% to $1.42 billion from the year-earlier quarter.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Celgene Corporation reported adjusted net income of $1.32 per share. By that measure, the company beat the mean analyst estimate of $1.31. It missed the average revenue estimate of $1.46 billion.

CELG

Bristol-Myers Squibb Company (NYSE:BMY) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Net income increased 8.57% to $925 million (47 cents per diluted share) in the quarter versus a net gain of $852 million in the year-earlier quarter. Revenue decreased 23.18% to $4.19 billion from the year-earlier quarter.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Bristol-Myers Squibb Company reported adjusted net income of 47 cents per share. By that measure, the company beat the mean analyst estimate of $0.43. It beat the average revenue estimate of $4.12 billion.

BMY

AmerisourceBergen Corporation (NYSE:ABC) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Net income increased 4% to $168.6 million (71 cents per diluted share) in the quarter versus a net gain of $162.12 million in the year-earlier quarter. Revenue rose 5.45% to $21.47 billion from the year-earlier quarter.

AmerisourceBergen Corporation reported adjusted net income of 71 cents per share. By that measure, the company beat the mean analyst estimate of $0.67. It missed the average revenue estimate of $21.69 billion.

ABC

Don’t Miss: IPOs, Lawsuits, and Cancer Treatments: Healthcare Recap.